Cancidas

Caspofungin Acetate

8.1 High risk

Cancidas & Product use in unapproved indication

13.3%

of users reported Product use in unapproved indication

69.2%

also reported Hospitalization

65.3%

are women

Most common medical consequences

Hospitalization
69.2%
Severe reaction
25.6%
Death
5.1%

Have you experienced any negative side effects from this medication?

Cancidas: general information

Most common side effects (31)

Most commonly affected ages

0 - 9 years
6.8%
10 - 19 years
5.8%
20 - 29 years
1.5%
30 - 39 years
5.9%
40 - 49 years
7.7%
50 - 59 years
16.8%
60 - 69 years
28.3%
70 - 79 years
16.6%
80 - 89 years
10.7%
On this page
Cancidas & Product use in unapproved indication
Cancidas: general information